/

Batteries & E-Mobility

/

Hepalink Group

Hepalink Group

Hepalink Group

Verified Nov 2026

Batteries & E-Mobility

·

China flag

Shenzhen, Guangdong

·

Since 1998

Hepalink Group is a biopharmaceutical company headquartered in Shenzhen, China, founded in 1998. The company employs 1,000–5,000 people and generates estimated revenue of $500M–$1B. It operates across pharmaceutical manufacturing, contract development and manufacturing services, and drug development for automotive, electric-vehicle, medical, and industrial-equipment sectors. The company produces heparin-related APIs and injections, including enoxaparin sodium, and operates GMP-compliant facilities in China and the United States.

Hepalink Group

Verified Nov 2026

AT A GLANCE

Founded

1998

Headquarters

China flag

Shenzhen, Guangdong

Employees

1,000-5,000

Ownership

Hepalink Group at a glance

Revenue

$500M-1B

Est. band

Employees

1,000-5,000

Founded

1998

Headquarters

Shenzhen, Guangdong

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Hepalink Group is a biopharmaceutical company headquartered in Shenzhen, China, founded in 1998. The company employs 1,000–5,000 people and generates estimated revenue of $500M–$1B. It operates across pharmaceutical manufacturing, contract development and manufacturing services, and drug development for automotive, electric-vehicle, medical, and industrial-equipment sectors. The company produces heparin-related APIs and injections, including enoxaparin sodium, and operates GMP-compliant facilities in China and the United States.

At a glance

Attribute

Detail

Founded

1998

Headquarters

Shenzhen, Guangdong

Employees

1,000-5,000

Revenue

$500M-1B (estimated)

Primary capability

Batteries & E-Mobility

What Hepalink Group makes

The company offers large-molecule biologics CDMO services including process development, analytical testing, formulation research, and mammalian cell culture production for pharmaceutical intermediates and APIs.

Latest developments

Company details

Hepalink is dual-listed in Hong Kong and mainland China and serves international pharmaceutical companies across Europe, the United States, Turkey, and Brazil. Hepalink Group was founded in 1998, has an estimated 1,000-5,000 employees, and is headquartered in Shenzhen, Guangdong.

Frequently asked questions

What does Hepalink Group make?

Hepalink Group is a biopharmaceutical company headquartered in Shenzhen, China, founded in 1998. The company employs 1,000–5,000 people and generates estimated revenue of $500M–$1B. It operates across pharmaceutical manufacturing, contract development and manufacturing services, and drug development for automotive, electric-vehicle, medical, and industrial-equipment sectors. The company produces heparin-related APIs and injections, including enoxaparin sodium, and operates GMP-compliant facilities in China and the United States.

Where is Hepalink Group headquartered?

Hepalink Group is headquartered in Shenzhen, Guangdong.

When was Hepalink Group founded?

Hepalink Group was founded in 1998.

How big is Hepalink Group?

Hepalink Group has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Shenzhen, Guangdong (HQ)Headquarters · Guangdong, China
Shenzhen, Guangdong (HQ)Shenzhen, Guangdong, ChinaHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.